F. Di Pierro
Weatherford College
- Papers in database
- 12
- Primary author
- 7 papers
- Years active
- 2013 – 2026
- Total publications
- 226
- Total citations
- 5,508
- h-index
- 37
Research Areas
- Gut microbiota and health
- Probiotics and Fermented Foods
- Silymarin and Mushroom Poisoning
- Oral microbiology and periodontitis research
- Streptococcal Infections and Treatments
Papers (12)
- 2026A One Health Decalogue for Breastfeeding: Microbiota-Targeted Strategies for Infant Gastrointestinal and Neurodevelopmental Health.10.3390/nu18071074
- 2025Management of symptomatic uncomplicated diverticular disease (SUDD) of the colon with Clostridium butyricum CBM588 versus rifaximin: a retrospective cross-sectional study.10.1007/s00384-025-05005-6
- 2025The Role of Targeted Microbiota Therapy in the Prevention and Management of Puerperal Mastitis.10.3390/diseases13060176
- 2025Primary authorStudy to evaluate the safety and tolerability of Streptococcus salivarius eK12, a genetically modified strain derived from the oral probiotic S. salivarius K12: Results from a randomized, double-blind, placebo-controlled, parallel-group clinical trial.10.3389/fnut.2025.1701611
- 2024Safety and efficacy of a class II medical device based on highly purified and standardized plant extracts in the management of post-menopausal patients with vulvar and vaginal atrophy: a single-center prospective observational study.10.23736/s2724-606x.23.05409-x
- 2022A Practical Perspective on the Use of Botanicals During the COVID-19 Pandemic: From Proven to Potential Interactions.10.1089/jmf.2021.0062
- 2021Primary authorOral administration of Lactobacillus crispatus M247 to papillomavirus-infected women: results of a preliminary, uncontrolled, open trial.10.23736/s2724-606x.21.04752-7
- 2021Primary authorOral administration of Lactobacillus crispatusM247 to papillomavirus-infected women: results of a preliminary, uncontrolled, open trial.10.23736/S2724-606X.21.04752-7
- 2021Primary authorBifidobacterium longum W11: Uniqueness and individual or combined clinical use in association with rifaximin.10.1016/j.clnesp.2020.12.025
- 2018Primary authorUse of Streptococcus salivarius K12 to reduce the incidence of pharyngo-tonsillitis and acute otitis media in children: a retrospective analysis in not-recurrent pediatric subjects.10.23736/S0026-4946.18.05182-4
- 2018Primary authorAssessment of Efficacy of BLIS-Producing Probiotic K12 for the Prevention of Group A Streptococcus Pharyngitis: a Short Communication10.1007/s12602-018-9398-7
- 2013Primary authorClinical evaluation of the oral probiotic Streptococcus salivarius K12 in the prevention of recurrent pharyngitis and/or tonsillitis caused by Streptococcus pyogenes in adults10.1517/14712598.2013.758711